GLP-1 Receptor Agonist as Adjuvant Therapy in Type 1 Diabetes: No Apparent Benefit for Beta-Cell Function or Glycemia.

导出 OA

翻译打印收藏纠错

作者： Maria J,Redondo ^[1] ; Fida,Bacha ^[2]

作者单位： Diabetes and Endocrinology Section, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas. ^[1] Diabetes and Endocrinology Section, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas.;Children's Nutrition Research Center, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas. ^[2]

关键词 GLP-1 receptor agonists albiglutide c-peptide clinical trial type 1 diabetes youth

主题词成年人(Adult);血糖(Blood Glucose);糖尿病, 1型(Diabetes Mellitus, Type 1);胰高血糖素样肽1(Glucagon-Like Peptide 1);人类(Humans)

DOI 10.1210/clinem/dgaa314

PMID 32485735

发布时间 2024-09-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交